Clinical Trials

Showing 81 - 100 of 454 trials
Title Investigatorsort icon Disease(s)
A Pilot Trial of Enoxaparin versus Aspirin in Patients with Cancer and Stroke
[Protocol 12-264]
De Angelis, Lisa
  • Solid Tumors
A Phase II Study of Temozolomide plus Irinotecan with or without Bevacizumab in Children with Recurrent or Refractory Medulloblastoma or PNET
[Protocol 11-089]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
A Phase III Study of Chemotherapy After Radiation in Young Patients with Newly Diagnosed Ependymoma
[Protocol 11-090]
De Braganca, Kevin
  • Pediatric Brain Tumors
    • Brain Cancer
    • CNS Cancer
A Pilot Study of Acupuncture to Control Symptoms in Patients Receiving Stem Cell Transplantation for Multiple Myeloma
[Protocol 13-038]
Deng, Gary
  • Blood & Marrow Stem Cell Transplantation
    • Autologous
  • Hematology
    • Multiple Myeloma
A Pilot Study of a Breathing Training Exercise to Reduce Chronic Shortness of Breath
[Protocol 12-261]
Deng, Gary
  • Lung Cancer
  • Survivorship
A Phase II Study of Fulvestrant Alone or with GDC-0941 or GDC-0980 in Women with Advanced Breast Cancer Resistant to Aromatase Inhibitor Therapy
[Protocol 12-029]
Dickler, Maura
  • Breast Cancer
A Phase II Study of Adjuvant Bevacizumab, Metronomic Chemotherapy, Diet, and Exercise After Preoperative Chemotherapy for Breast Cancer
[Protocol 11-063]
Dickler, Maura
  • Breast Cancer
A Phase III Study of BKM120 with Fulvestrant in Postmenopausal Women with Locally Advanced or Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer
[Protocol 12-290]
Dickler, Maura
  • Breast Cancer
A Phase I Study of ARN-810 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer
[Protocol 13-049]
Dickler, Maura
  • Breast Cancer
A Phase I Study of BYL719 with Letrozole or Exemestane for Treating Locally Advanced Inoperable or Metastatic Breast Cancer
[Protocol 13-027]
Dickler, Maura
  • Breast Cancer
A Phase I Study of AMP-224 with a Cyclophosphamide-Containing Regimen in Patients with Advanced Melanoma
[Protocol 12-127]
Dickson, Mark
  • Melanoma
A Phase II Study of PD0332991 in Patients with Advanced or Metastatic Liposarcoma
[Protocol 10-094]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark
  • Sarcomas
    • Soft Tissue Sarcoma
A Pilot Trial of Bortezomib in Patients with Relapsed/Refractory AIDS-associated Kaposi Sarcoma
[Protocol 10-117]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Phase I/II Study of Lenalidomide in Patients with AIDS-Associated Kaposi's Sarcoma
[Protocol 10-116]
Dickson, Mark
  • AIDS-Associated Cancers
    • AIDS-Associated Kaposi's Sarcoma
A Clinical Study of McGhan Corporation-Style 410 Silicone-Filled Breast Implants
[Protocol 06-024]
Disa, Joseph
  • Breast Cancer
  • Survivorship
A Phase I Study of BMS-906024 in Patients with Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or T-Cell Lymphoblastic Lymphoma
[Protocol 11-181]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia
  • Lymphoma
    • Non-Hodgkin's Lymphoma
A Phase III Study of Elacytarabine versus Investigator's Choice in Patients with Late-Stage Acute Myeloid Leukemia
[Protocol 10-113]
Douer, Dan
  • Leukemia
    • Acute Myelogenous Leukemia
A Phase I Study of Actinium-225-Labeled HuM195 Antibody in Patients with Advanced Myeloid Malignancies
[Protocol 02-017]
Douer, Dan
  • Hematology
    • Myelodysplastic Syndrome
  • Leukemia
    • Acute Myelogenous Leukemia
    • Chronic Myelocytic Leukemia
    • Myelodysplastic Syndrome
A Phase II Study of Blinatumomab in Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
[Protocol 12-069]
Douer, Dan
  • Leukemia
    • Acute Lymphoblastic Leukemia